Targeting molecules that when circulated within the bloodstream tend to bind to malignant cells and minimize attachment to healthy tissue cells and benign tumor cells. The targeting molecule is designed to be detectable such that it can be identified by various means such as an MRI, X-ray, ultrasound, chromatically visible to the eye, and any other useful means of detection.
